Market Overview

From Earlier: Illumina Launches Infinium HumanCore Arrays for Economical Large-Scale Genetic Studies

Share:
Related ILMN
Morgan Stanley Sees Illumina Trading At Too High A Premium To Its Peers
5 Largest Price Target Changes For Tuesday
Is Biotech Finally Ready To Move Higher? (Seeking Alpha)

Illumina, Inc. (NASDAQ: ILMN) today launched the Infinium HumanCore BeadChip family of products. With content developed in collaboration with several leading research institutions, the customizable Infinium HumanCore and Infinium HumanCoreExome BeadChips support cost-effective, large-scale genotyping and screening studies such as those performed by biobanks, genome centers, and core labs. Based on Illumina's proven Infinium assay, the BeadChips enable genotyping of markers found across diverse populations, making them ideal for researchers engaged in population genetics studies around the world.

Posted-In: News FDA

 

Related Articles (ILMN)

View Comments and Join the Discussion!